Frontlight ResearchEarly access
Trial site
Inje University Sanggye Paik Hospital
- 5running trials
- 6closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Parkinson disease2 trials
- Asthma1 trial
- Atrial fibrillation1 trial
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Crohn's disease1 trial
- Idiopathic pulmonary fibrosis1 trial
- Lung cancer1 trial
- Multiple myeloma1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Phase 42 trials
- Status
- Completed6 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Lead sponsor
- Boehringer Ingelheim1 trial
- Celgene1 trial
- Eli Lilly and Company1 trial
- Glaceum1 trial
- Heuron Inc.1 trial
- and 6 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation1 recruiting
- Coronary artery disease1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026